Bivalirudin versus Heparin Monotherapy in Myocardial Infarction
David Erlinge(Lund University), Stefan James(Uppsala University), Pontus Lindroos(Karolinska Institutet), Loghman Henareh(Karolinska University Hospital), Lotta Robertsson(Södra Älvsborg Hospital), Fredrik Scherstén(Lund University), Eva Swahn(Linköping University), Peter Hårdhammar(Halmstad University), Mehmet Hamid(Karolinska University Hospital), Peter Eriksson(Sahlgrenska University Hospital), Helena Wikström(Örebro University Hospital), Dan Ioanes(Sahlgrenska University Hospital), Anders Ulvenstam(Östersunds Hospital), Truls Råmunddal(Sahlgrenska University Hospital), Jason Stewart(Örebro University Hospital), Rikard Linder(Karolinska University Hospital), Bo Lagerqvist(Uppsala University), Bo Lindvall(Sundsvall Municipality), Ole Fröbert(Aarhus University), Jan Haupt(Sunderby sjukhus), Leszek Zagozdzon(Örebro University), Lars Wallentin(Uppsala University), Iwar Sjögren(Falun Hospital), Tim Tödt(Linköping University Hospital), Pallonji Bhiladvala(Lund University), Mikael Danielewicz(Örebro University Hospital), Per Grimfjärd(Uppsala University Hospital), Oskar Angerås(Sahlgrenska University Hospital), Jonas Andersson(Skellefteå Hospital), Elmir Ömerovic(Sahlgrenska University Hospital), Claes Held(Uppsala University), Thomas Kellerth(Karolinska University Hospital), Ollie Östlund(Karolinska University Hospital), Jens Jensen(Karolinska Institutet), Henrik Wagner(Örebro University Hospital), Anders Lundin(Unknown), Mikael Aasa(Stockholm South General Hospital), Sasha Koul(Lund University), Matthias Götberg
Cited by 298
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k